Figure 1From: Differential survival following trastuzumab treatment based on quantitative HER2 expression and HER2 homodimers in a clinic-based cohort of patients with metastatic breast cancer Relationship between ICH results and HER mark measures of HER2. (a) Screening IHC results correlated with HER2 expression. (b) Repeat IHC results, all patients (compare to Figure S1).Back to article page